文献速递肝病

高胆固醇血症与原发性胆汁性胆管炎脂代谢紊乱及不良预后相关

Hypercholesterolemia Is Associated With Dysregulation of Lipid Metabolism and Poor Prognosis in Primary Biliary Cholangitis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2024-02-13

基线TC独立与不良肝脏相关结局相关,衍生队列调整C统计量为0.80(95%CI 0.74-0.85),验证队列为0.88(95%CI 0.78-0.91);200 mg/dL切点可最优划分低TC和高TC组。脂质组学显示高TC患者甘油磷脂和鞘脂代谢紊乱,并与不良肝脏相关结局相关。

要点

  • 基线TC升高是PBC患者不良肝脏相关结局的独立危险因素。
  • TC预测能力与Globe评分相当,联合Globe评分可更准确进行风险分层。
  • 基线TC>200 mg/dL的PBC患者具有独特脂质组学特征且预后更差。

核心结论

  • 基线TC水平>200 mg/dL的PBC患者具有独特脂质组学特征,且不良肝脏相关结局风险更高。

主要发现

  • 基线TC独立与不良肝脏相关结局相关,衍生队列调整C统计量为0.80(95%CI 0.74-0.85),验证队列为0.88(95%CI 0.78-0.91)。
  • TC对疾病结局的预测能力随时间稳定,与Globe评分相当。
  • 200 mg/dL切点最优划分低TC和高TC组,TC联合Globe评分可更准确进行风险亚组分层。
  • 脂质组学显示高TC患者脂质家族上调,66种上调脂质的通路分析揭示甘油磷脂和鞘脂代谢紊乱,且与不良肝脏相关结局相关。

关键数值与推荐

  • 基线TC>200 mg/dL为高TC组切点。
  • 衍生队列调整C统计量0.80(95%CI 0.74-0.85),验证队列0.88(95%CI 0.78-0.91)。

临床怎么用

  • 对PBC患者应关注基线TC水平,TC>200 mg/dL提示不良肝脏相关结局风险较高。
  • 可将TC与Globe评分联合用于PBC患者风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Hypercholesterolemia is frequently diagnosed in patients with primary biliary cholangitis (PBC). However, its association with the prognosis and lipid metabolism is unknown. In this study, we aimed to investigate the prognostic value of baseline total cholesterol (TC) levels in PBC and characterized the associated lipid metabolism. METHODS: Five hundred and thirty-one patients with PBC without prior cirrhosis-related complications were randomly divided into the derivation and validation cohorts at a ratio of 7:3. Complete clinical data were obtained and analyzed. The endpoints were defined as liver-related death, liver transplantation, and cirrhosis-related complications. Lipidomics was performed in 89 patients and 28 healthy controls. RESULTS: Baseline TC was independently associated with poor liver-related outcomes, and adjusted C-statistics were 0.80 (95% confidence interval [CI]: 0.74-0.85) and 0.88 (95% CI: 0.78-0.91) in the derivation and validation cohorts, respectively. The predictive ability of TC for disease outcomes was stable over time and comparable with the Globe score. The 200 mg/dL cut-off optimally divided patients into low- and high-TC groups. A combination of TC and Globe score provided a more accurate stratification of patients into risk subgroups. Lipidomics indicated an up-regulation of lipid families in high-TC patients. Pathway analysis of 66 up-regulated lipids revealed the dysregulation of glycerophospholipid and sphingolipid metabolism in high-TC patients, which were associated with poor liver-related outcomes. CONCLUSIONS: Our results indicate that patients with PBC having baseline TC levels above 200 mg/dL have unique lipidome characteristics and are at a higher risk of poor liver-related outcomes.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Zheng L, Tian S, Yang C, et al. Hypercholesterolemia Is Associated With Dysregulation of Lipid Metabolism and Poor Prognosis in Primary Biliary Cholangitis. Clin Gastroenterol Hepatol. 2024. PMID: 38354969. doi:10.1016/j.cgh.2024.01.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。